| NDC-11 (Package) | NDC-9 (Product) | Generic Name | Brand Name | Strength | SEER*Rx Category | Major Class | Minor Class | Administration Route | Package Effective Date | Package Discontinuation Date | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 00074-3642-03 | 00074-3642 | Leuprolide Acetate | Lupron Depot | 7.5 mg/mL | Hormonal Therapy | GnRH Agonist | Intramuscular | Jan 27, 1989 | In Use | ||
| 43063-0446-30 | 43063-0446 | Estradiol | Estradiol | 1.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Apr 18, 2013 | Jan 24, 2019 | In Use | |
| 83831-0159-02 | 83831-0159 | Fulvestrant | CLIGAVYX | 250.0 mg/5mL | Hormonal Therapy | Estrogen Receptor Antagonist | Intramuscular | Jul 1, 2026 | In Use | ||
| 00074-3642-55 | 00074-3642 | Leuprolide Acetate | Lupron Depot | 7.5 mg/mL | Hormonal Therapy | GnRH Agonist | Intramuscular | Mar 15, 2026 | In Use | ||
| 10544-0070-30 | 10544-0070 | Estradiol | Estradiol | 2.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Mar 5, 2012 | In Use | ||
| 55289-0761-30 | 55289-0761 | Estradiol | Estradiol | 1.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Dec 21, 2009 | Nov 23, 2021 | No Longer Used | |
| 00074-3683-03 | 00074-3683 | Leuprolide Acetate | Lupron Depot | 30.0 mg/1.5mL | Hormonal Therapy | GnRH Agonist | Intramuscular | Dec 23, 1995 | In Use | ||
| 51862-0682-00 | 51862-0682 | TAMOXIFEN CITRATE | SOLTAMOX | 20.0 mg/10mL | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | Dec 6, 2021 | In Use | ||
| 00074-3683-55 | 00074-3683 | Leuprolide Acetate | Lupron Depot | 30.0 mg/1.5mL | Hormonal Therapy | GnRH Agonist | Intramuscular | Mar 15, 2026 | In Use | ||
| 24535-0801-01 | 24535-0801 | Letrozole | Letrozole | 2.5 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | Jun 3, 2016 | In Use | ||
| 00310-0720-10 | 00310-0720 | Fulvestrant | Faslodex | 50.0 mg/mL | Hormonal Therapy | Estrogen Receptor Antagonist | Intramuscular | Nov 1, 2010 | In Use | ||
| 68382-0826-06 | 68382-0826 | Tamoxifen Citrate | Tamoxifen Citrate | 10.0 mg/1 | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | Jan 3, 2018 | Dec 5, 2019 | In Use | |
| 61919-0278-60 | 61919-0278 | Estradiol | Estradiol | 1.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Aug 12, 2019 | In Use | ||
| 63629-4413-01 | 63629-4413 | Tamoxifen Citrate | Tamoxifen Citrate | 20.0 mg/1 | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | Mar 7, 2011 | In Use | ||
| 85043-0075-05 | 85043-0075 | Leuprolide acetate | Vabrinty | 7.5 mg/.25mL | Hormonal Therapy | GnRH Agonist | Subcutaneous | Dec 15, 2025 | In Use | ||
| 52544-0153-02 | 52544-0153 | Triptorelin Pamoate | Trelstar | 3.75 mg/2mL | Hormonal Therapy | GnRH Agonist | Intramuscular | Jun 15, 2000 | Oct 31, 2018 | No Longer Used | |
| 50090-2533-01 | 50090-2533 | Tamoxifen Citrate | Tamoxifen Citrate | 10.0 mg/1 | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | Feb 20, 2018 | Feb 20, 2018 | No Longer Used | |
| 00179-0220-70 | 00179-0220 | Raloxifene Hydrochloride | Raloxifene Hydrochloride | 60.0 mg/1 | Hormonal Therapy | Selective Estrogen Receptor Modulator (SERM) | Oral | Oct 12, 2016 | Mar 31, 2018 | In Use | |
| 68788-9901-03 | 68788-9901 | Estradiol | Estradiol | 1.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Feb 13, 2012 | Sep 9, 2019 | No Longer Used | |
| 00555-0779-04 | 00555-0779 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 10.0 mg/1 | Hormonal Therapy | Progestin | Oral | Dec 4, 1996 | In Use | ||
| 68788-9416-09 | 68788-9416 | Estradiol | Estradiol | 1.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Dec 4, 2014 | Sep 9, 2019 | No Longer Used | |
| 54868-5261-00 | 54868-5261 | Exemestane | Aromasin | 25.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | Jun 29, 2005 | In Use | ||
| 70518-2369-02 | 70518-2369 | Estradiol | Estradiol | 2.0 mg/1 | Hormonal Therapy | Estrogen | Oral | May 25, 2023 | In Use | ||
| 59572-0711-01 | 59572-0711 | Luspatercept | REBLOZYL | 25.0 mg/1 | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Subcutaneous | Nov 8, 2019 | In Use | ||
| 64679-0632-01 | 64679-0632 | Octreotide Acetate | Octreotide Acetate | 1000.0 ug/mL | Hormonal Therapy | Somatostatin Analog | Intravenous, Subcutaneous | May 11, 2011 | In Use |
Found 12482 results — Export these results
Home